BIOEXSEN GmbH

BioeXsen develops products for rapid pathogen diagnosis with molecular biotechnology tools in the area of human health with the production and distribution of immunobiological and isopathic medicinal products in human biology. BioeXsen SARS-CoV-2 kits provide RT-qPCR solution that is fast, simple, accurate, cost-effective and high throughput. Our PCR solutions allow simultaneous detection and distinguishing SARS-CoV-2, and the emerging mutant variants in a single reaction.